Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Rashi Peripherals Limited Capital/Financing Update 2025

Aug 5, 2025

59614_rns_2025-08-05_3730136d-37a8-473b-8305-8de323232e9e.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

August 5, 2025

To, Listing Operation Department BSE Limited Phiroze Jeejecbhoy Towers Dalal Street, Mumbai- 400001

Scrip Code: 544119

Listing Compliance Department

The National Stock Exchange of India Limited (NSE) 05[th] Floor, Exchange Plaza, C-1, Block G, Bandra Kurla Complex, Bandra (E) Mumbai - 400051

Symbol: RPTECH

Sub : Report of the Monitoring Agency with respect to utilization of proceeds of the Initial Public Offering of Rashi Peripherals Limited (“the Company”)

Dear Sir/Madam,

Pursuant to Regulation 32(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Regulation 41(4) of SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, please find enclosed the Monitoring Agency Report dated August 5, 2025 in respect of utilization of proceeds of the fresh issue of the Initial Public Offering of the Company, issued by CARE Rating Limited (Monitoring Agency appointed by the Company) for the quarter ended June 30, 2025.

You are requested to kindly take the same on record.

Thankyou. Yours faithfully, For RASHI PERIPHERALS LIMITED KRISHNA KUMAR CHOUDHARY Digitally signed by KRISHNA KUMAR CHOUDHARY DN: c=IN, o=Personal, postalCode=400056, st=Maharashtra, serialNumber=31E0C485DB89415A7F7FD627F78F73C056BFE5B9DB0D78FA69A42FFFC5DCDA6A, cn=KRISHNA KUMAR CHOUDHARY

Krishna Kumar Choudhary Chairman & Whole-Time Director DIN: 00215919

Encl.: As above

==> picture [567 x 89] intentionally omitted <==

Rashi Peripherals Limited

Regd. Office: Ariisto House, 5th Floor, N S Phadke Road, Andheri East, Mumbai, Maharashtra – 400069, India

• Tel: +91-22-6177 1771 | Fax +91-22-61771999 • www.rptechindia.com | CIN: L30007MH1989PLC051039

Agency Report

Final Monitoring Agency Report

==> picture [6 x 20] intentionally omitted <==

==> picture [172 x 48] intentionally omitted <==

==> picture [4 x 15] intentionally omitted <==

==> picture [4 x 15] intentionally omitted <==

==> picture [4 x 15] intentionally omitted <==

No. CARE/HO/GEN/2025-26/1094

The Board of Directors Rashi Peripherals Limited Ariisto House, 5th Floor, Junction of N.S.Phadke Road, Telli Gali, Andheri (E), Mumbai- 400 069, Maharashtra, India.

August 05, 2025

Dear Sir/Ma’am,

Monitoring Agency Report for the quarter ended June 30, 2025 - in relation to the IPO of Rashi Peripherals Limited (“the Company”)

We write in our capacity of Monitoring Agency for the Initial Public Offer (IPO) for the amount aggregating to Rs. 600 crore of the Company and refer to our duties cast under Section 41 of the Securities & Exchange Board of India (Issue of Capital & Disclosure Requirements) Regulations.

In this connection, we are enclosing the Monitoring Agency Report for the quarter ended June 30, 2025, as per aforesaid SEBI Regulations and Monitoring Agency Agreement dated April 10, 2024.

Request you to kindly take the same on records.

Thanking you, Yours faithfully,

==> picture [82 x 49] intentionally omitted <==

Sonal Bhageria Associate Director [email protected]

==> picture [40 x 34] intentionally omitted <==

CARE Ratings Limited

4th Floor, Godrej Coliseum, Somaiya Hospital Road, Off Eastern Express Highway, Sion (East), Mumbai Phone: +91-22-6754 3456 • www.careedge.in

CIN-L67190MH1993PLC071691

Report of the Monitoring Agency

Name of the issuer: Rashi Peripherals Limited For quarter ended: June 30, 2025 Name of the Monitoring Agency: CARE Ratings Limited

  • (a)Deviation from the objects: Nil

  • (b)Range of Deviation: Not applicable

Declaration:

We declare that this report provides an objective view of the utilization of the issue proceeds in relation to the objects of the issue based on the information provided by the Issuer and information obtained from sources believed by it to be accurate and reliable. The MA does not perform an audit and undertakes no independent verification of any information/ certifications/ statements it receives. This Report is not intended to create any legally binding obligations on the MA which accepts no responsibility, whatsoever for loss or damage from the use of the said information. The views and opinions expressed herein do not constitute the opinion of MA to deal in any security of the Issuer in any manner whatsoever. Nothing mentioned in this report is intended to or should be construed as creating a fiduciary relationship between the MA and any issuer or between the agency and any user of this report. The MA and its affiliates also do not act as an expert as defined under Section 2(38) of the Companies Act, 2013.

The MA or its affiliates may have credit rating or other commercial transactions with the entity to which the report pertains and may receive separate compensation for its ratings and certain credit related analyses. We confirm that there is no conflict of interest in such relationship/interest while monitoring and reporting the utilization of the issue proceeds by the issuer, or while undertaking credit rating or other commercial transactions with the entity.

We have submitted the report herewith in line with the format prescribed by SEBI, capturing our comments, where applicable. There are certain sections of the report under the title “Comments of the Board of Directors”, that shall be captured by the Issuer’s Management / Audit Committee of the Board of Directors subsequent to he MA submitting their report to the issuer and before dissemination of the report through stock exchanges. These sections have not been reviewed by the MA, and the MA takes no responsibility for such comments of the issuer’s Management/Board.

==> picture [92 x 44] intentionally omitted <==

Signature: Name and designation of the Authorized Signatory: Sonal Bhageria Designation of Authorized person/Signing Authority: Associate Director

==> picture [40 x 34] intentionally omitted <==

CARE Ratings Limited

4th Floor, Godrej Coliseum, Somaiya Hospital Road, Off Eastern Express Highway, Sion (East), Mumbai Phone: +91-22-6754 3456 • www.careedge.in

CIN-L67190MH1993PLC071691

1) Issuer Details: Name of the issuer : Rashi Peripherals Limited Name of the promoter : Krishna Kumar Choudhary, Sureshkumar Pansari, Kapal Suresh Pansari, Keshav Krishna Kumar Choudhary, Chaman Pansari, Krishna Kumar Choudhary (HUF), and Suresh M Pansari (HUF).

Industry/sector to which it belongs

: ICT Product Distribution

2) Issue Details Issue Period : 02/07/2024 to 02/09/2024 Type of issue (public/rights) : IPO Type of specified securities : Equity Shares IPO Grading, if any : Not Applicable Issue size (in crore) : Rs. 600 crores

==> picture [40 x 34] intentionally omitted <==

CARE Ratings Limited

4th Floor, Godrej Coliseum, Somaiya Hospital Road, Off Eastern Express Highway, Sion (East), Mumbai Phone: +91-22-6754 3456 • www.careedge.in

==> picture [122 x 171] intentionally omitted <==

CIN-L67190MH1993PLC071691

3) Details of the arrangement made to ensure the monitoring of issue proceeds:

Particulars Reply Source of information / certifications
considered by Monitoring Agency for
preparation of report
Comments of the
Monitoring Agency
Comments of the
Board of Directors
Whether all utilization is as per the disclosures in the
Offer Document?
Yes CA Certificate*
Bank Statements and Invoices
Nil No
comments
received
Whether shareholder approval has been obtained in case
of material deviations# from expenditures disclosed in
the Offer Document?
Not applicable as no deviation Company declaration Nil No
comments
received
Whether the means of finance for the disclosed objects of
the issue have changed?
No Company declaration Nil No
comments
received
Is there any major deviation observed over the earlier
monitoring agency reports?
Not applicable Not Applicable No deviations observed
from the last monitoring
agency report
No
comments
received
Whether all Government/statutory approvals related to
the object(s) have been obtained?
Not applicable Company declaration (RHP In-
principal approval)
Nil No
comments
received
Whether all arrangements pertaining to technical
assistance/collaboration are in operation?
Yes Company declaration (BSE & NSE
Software purchased)
Nil No
comments
received
Are there any favourable/unfavourable events affecting
the viability of these object(s)?
No Company declaration Nil No
comments
received
Is there any other relevant information that may
materially affect the decision making of the investors?
No Company declaration Nil No
comments
received

*Chartered Accountant certificate from PIPARA & Co LLP, Chartered Accountants, dated July 30, 2025

Where material deviation may be defined to mean:

a) Deviation in the objects or purposes for which the funds have been raised

b) Deviation in the amount of funds actually utilized by more than 10% of the amount projected in the offer documents.

==> picture [41 x 34] intentionally omitted <==

CARE Ratings Limited

4th Floor, Godrej Coliseum, Somaiya Hospital Road, Off Eastern Express Highway, Sion (East), Mumbai Phone: +91-22-6754 3456 • www.careedge.in

==> picture [122 x 171] intentionally omitted <==

CIN-L67190MH1993PLC071691

4) Details of objects to be monitored:

(i) Cost of objects –

Sr.
No
Item
Head
Source of information /
certifications considered by
Monitoring Agency for
preparation of report
Original cost
(as per the Offer
Document) in Rs.
Crore
Revised Cost
in Rs. Crore
Comments of
the
Monitoring
Agency
Comments of the Board of Directors Comments of the Board of Directors Comments of the Board of Directors
Reason for cost
revision
Proposed
financing option
Particulars of -
firm
arrangements
made
1 Prepayment or scheduled re-
payment of all or a portion of
certain outstanding
borrowings availed by our
company
Offer Document 326.00 NA Nil No comments
received
No comments
received
No comments
received
2 Funding working capital
requirements of our company
Offer Document 220.00 NA Nil No comments
received
No comments
received
No comments
received
3 General Corporate Purpose Offer Document 8.14 NA Nil No comments
received
No comments
received
No comments
received
Total 554.14 NA

==> picture [41 x 34] intentionally omitted <==

CARE Ratings Limited

4th Floor, Godrej Coliseum, Somaiya Hospital Road, Off Eastern Express Highway, Sion (East), Mumbai Phone: +91-22-6754 3456 • www.careedge.in

==> picture [122 x 171] intentionally omitted <==

CIN-L67190MH1993PLC071691

– (ii) Progress in the objects

Sr.
No
Source of
information
/
Amount as
proposed
Amount utilised in Rs. Crore Amount utilised in Rs. Crore Unutilise Comments of the Board
of Directors
Comments of the Board
of Directors
At the Proposed
course of
action
certifications
Item
considered
in the Offer During end of d amount Comments of the
ii
Reasons

i
Head by
ii
Document in As at beginning of the
the the n Rs. Montorng Agency for idle
Montorng
Agency for
preparation
of report
Rs. Crore quarter in Rs. Crore quarter in quarter crore funds

Rs. Crore

in Rs.
Crore
1 Prepayment or
scheduled re-payment
of all or a portion of
certain outstanding
borrowings availed by
our company
CA certificate
Offer
Document
326.00 326.00 - 326.00 0.00 Nil No
comments
received
No
comments
received
2 Funding working
capital requirements
of our company
CA certificate
Offer
Document
220.00 220.00 - 220.00 0.00 Nil No
comments
received
No
comments
received
3 General Corporate
Purpose
CA certificate
Offer
Document
8.14 2.35 0.27 2.62 5.52 The original timeline
for utilizing the IPO
proceeds
allocated
towards
General
Corporate
Purposes
(GCP) was set to
conclude by the end
of fiscal year 2024. As
outlined in the offer
document,
any
unutilized
amount
could
be
carried
forward for use in the
subsequent
fiscal
year,
i.e.,
FY2025.
No
comments
received
No
comments
received
CARE Ratings Limited
4th Floor, Godrej Coliseum, Somaiya Hospital Road, Off Eastern Express Highway, Sion (East), Mumbai
Phone: +91-22-6754 3456 • www.careedge.in
CIN-L67190MH1993PLC071691
Sr.
No
Source of
information
/
Amount as
proposed
Amount utilised in Rs. Crore Amount utilised in Rs. Crore Unutilise Comments of the Board
of Directors
Comments of the Board
of Directors
At the Proposed
course of
action
certifications
Item
d
considered
b
in the Offer During end of d amount Comments of the
ii
Reasons

i
Hea y
Document in As at beginning of the
the the n Rs. Montorng Agency for idle
Monitoring
Agency for
preparation
of report
Rs. Crore quarter in Rs. Crore quarter in quarter crore funds

Rs. Crore

in Rs.
Crore
However,
the
Company
has
now
extended this timeline
through
a
Board
resolution dated April
21, 2025. According
to the resolution, the
utilization
of
the
remaining
funds
is
now expected to be
completed by the end
of fiscal year 2026 or
thereafter. As of June
30, 2025, an amount
of Rs.
5.52
crore
earmarked for GCP
remains unutilized.
Total 554.14 548.35 0.27 548.62 5.52

==> picture [42 x 35] intentionally omitted <==

CARE Ratings Limited

4th Floor, Godrej Coliseum, Somaiya Hospital Road, Off Eastern Express Highway, Sion (East), Mumbai Phone: +91-22-6754 3456 • www.careedge.in

==> picture [122 x 171] intentionally omitted <==

CIN-L67190MH1993PLC071691

(iii)Deployment of unutilised IPO proceeds:

Sr. No. Type of instrument and name of the
entity invested in
Amount invested (Rs.
crore)
Maturity date Earning (Rs. crore) Return on Investment
(%)
Market Value as at the end
of quarter
1. Axis Public Issue a/c –
924020005512318
1.60* NA NA NA 1.60
2. IndusInd Monitoring A/c –
256001800038
5.52 NA NA NA 5.52
  • Unspent issue expenses of Rs. 1.60 crore.

==> picture [41 x 34] intentionally omitted <==

CARE Ratings Limited

4th Floor, Godrej Coliseum, Somaiya Hospital Road, Off Eastern Express Highway, Sion (East), Mumbai Phone: +91-22-6754 3456 • www.careedge.in

==> picture [122 x 171] intentionally omitted <==

CIN-L67190MH1993PLC071691

(iv) Delay in implementation of the object(s)

Comments of the Board Comments of the Board
Completion Date
of Directors
Delay (no. of
Objects As per the Proposed

days/ months)

Reason of

offer
Actual
course of
delay
document action
Prepayment or scheduled re-
payment of all or a portion of
certain outstanding borrowings
availed by our company*

By FY24
02/15/2024 –
09/13/2024
5.5 Months* No
comments
received
No
comments
received
Funding working capital
requirements of our company
By FY24 02/15/2024 –
03/31/2024
- No
comments
received
No
comments
received
General Corporate Purpose* By FY24 Ongoing Delay (Exact
number of days
of delay not
ascertainable)*

No
comments
received
No
comments
received
  • Company proposes to deploy the entire Net Proceeds towards the Objects as per the schedule mentioned in the offer document. In the event that the estimated utilization is not completed as per the aforementioned schedule, due to the reasons stated in the offer document, such funds shall be utilized in the next fiscal year, as may be determined by the Company, in accordance with applicable law. The company undertakes not to utilize any spill over from the remaining Objects of the Offer towards our general corporate purposes.

The original timeline for utilizing the IPO proceeds allocated towards General Corporate Purposes (GCP) was set to conclude by the end of fiscal year 2024. As outlined in the offer document, any unutilized amount could be carried forward for use in the subsequent fiscal year, i.e., FY2025. However, the Company has now extended this timeline through a Board resolution dated April 21, 2025. According to the resolution, the utilization of the remaining funds is now expected to be completed by the end of fiscal year 2026 or thereafter. As of June 30, 2025, an amount of ₹5.52 crore earmarked for GCP remains unutilized.

5) Details of utilization of proceeds stated as General Corporate Purpose (GCP) amount in the offer document: Rs.0.27 crore spent during the period 04/01/2025 to 06/30/2025.

Source of
information /
certifications
Comments of the
Sr. Amount in Rs. considered
Item Head Comments of Monitoring Agency Board of
No Crore by Monitoring
Directors
Agency for

preparation of

report
1. Capital
Expenditure
0.27 CA certificate,
Bank
Statements and
PO

The company has spent Rs.0.27
crore towards capex out of the
GCP amount allocated.


No
comments
received
Total 0.27

^ Section from the offer document related to GCP: “Our Company intends to deploy the balance Net Proceeds aggregating up to Rs.8.14 crore in utilizing the proceeds earmarked for general corporate purposes.

==> picture [40 x 34] intentionally omitted <==

CARE Ratings Limited

4th Floor, Godrej Coliseum, Somaiya Hospital Road, Off Eastern Express Highway, Sion (East), Mumbai Phone: +91-22-6754 3456 • www.careedge.in

CIN-L67190MH1993PLC071691

Disclaimers to MA report:

a) This Report is prepared by CARE Ratings Ltd (hereinafter referred to as “Monitoring Agency/MA” ). The MA has taken utmost care to ensure accuracy and objectivity while developing this Report based on the information provided by the Issuer and information obtained from sources believed by it to be accurate and reliable. The views and opinions expressed herein do not constitute the opinion of MA to deal in any security of the Issuer in any manner whatsoever.

b) This Report has to be seen in its entirety; the selective review of portions of the Report may lead to inaccurate assessments. For the purpose of this Report, MA has relied upon the information provided by the management /officials/ consultants of the Issuer and third-party sources like statutory auditors (or from peer reviewed CA firms) appointed by the Issuer believed by it to be accurate and reliable.

c) Nothing contained in this Report is capable or intended to create any legally binding obligations on the MA which accepts no responsibility, whatsoever, for loss or damage from the use of the said information. The MA is also not responsible for any errors in transmission and specifically states that it, or its directors, employees do not have any financial liabilities whatsoever to the users of this Report.

d) The MA and its affiliates do not act as a fiduciary. The MA and its affiliates also do not act as an expert to the extent defined under Section 2(38) of the Companies Act, 2013. While the MA has obtained information from sources it believes to be reliable, it does not perform an audit and undertakes no independent verification of any information/ certifications/ statements it receives from auditors (or from peer reviewed CA firms), lawyers, chartered engineers or other experts, and relies on in its reports.

e) The MA or its affiliates may have other commercial transactions with the entity to which the report pertains. As an example, the MA may rate the issuer or any debt instruments / facilities issued or proposed to be issued by the issuer that is subject matter of this report. The MA may receive separate compensation for its ratings and certain credit-related analyses, normally from issuers or underwriters of the instruments, facilities, securities or from obligors.

==> picture [40 x 34] intentionally omitted <==

CARE Ratings Limited

4th Floor, Godrej Coliseum, Somaiya Hospital Road, Off Eastern Express Highway, Sion (East), Mumbai Phone: +91-22-6754 3456 • www.careedge.in

CIN-L67190MH1993PLC071691